You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

Investigational Drug Information for Fluoropyrimidine


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Fluoropyrimidine?

Fluoropyrimidine is an investigational drug.

There have been 328 clinical trials for Fluoropyrimidine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Eli Lilly and Company, and Hoffmann-La Roche.

There are seven hundred and fifty-one US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Fluoropyrimidine
TitleSponsorPhase
The Efficacy and Safety of Fruquintinib Plus FOLFIRI as Second-line Treatment in RAS-mutated Metastatic Colorectal CancerHunan Cancer HospitalPhase 2
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal CancerMEI Pharma, Inc.Phase 1
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaNational Cancer Institute (NCI)Phase 3

See all Fluoropyrimidine clinical trials

Clinical Trial Summary for Fluoropyrimidine

Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine

See all Fluoropyrimidine clinical trials

US Patents for Fluoropyrimidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoropyrimidine ⤷  Try a Trial Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) ⤷  Try a Trial
Fluoropyrimidine ⤷  Try a Trial Combination therapies for cancer MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH) ⤷  Try a Trial
Fluoropyrimidine ⤷  Try a Trial Tapered looped suture Covidien LP (Mansfield, MA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluoropyrimidine

Drugname Country Document Number Estimated Expiration Related US Patent
Fluoropyrimidine World Intellectual Property Organization (WIPO) WO2013071079 2031-11-09 ⤷  Try a Trial
Fluoropyrimidine European Patent Office EP3003316 2033-05-31 ⤷  Try a Trial
Fluoropyrimidine Spain ES2822665 2033-05-31 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.